BIP
Blueprint Investment Partners Portfolio holdings
AUM
$564M
This Quarter Return
+7.51%
1 Year Return
+15.06%
3 Year Return
+69.93%
5 Year Return
+121.15%
10 Year Return
–
AUM
$472M
AUM Growth
+$472M
(+29%)
Cap. Flow
+$89M
Cap. Flow
% of AUM
18.84%
Top 10 Holdings %
Top 10 Hldgs %
42.13%
Holding
260
New
101
Increased
88
Reduced
27
Closed
33
Top Buys
Top Sells
| 1 |
iShares Short Treasury Bond ETF
SHV
|
$28.4M |
| 2 |
SPDR Bloomberg 1-3 Month T-Bill ETF
BIL
|
$12M |
| 3 |
Apple
AAPL
|
$11.2M |
| 4 |
Tesla
TSLA
|
$3.47M |
| 5 |
iShares Gold Trust
IAU
|
$3.03M |
Sector Composition
| 1 | Healthcare | 4.93% |
| 2 | Financials | 4.22% |
| 3 | Energy | 3.56% |
| 4 | Consumer Staples | 3.18% |
| 5 | Technology | 2.77% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
101
iShares MSCI South Korea ETF
EWY
$5.1B
| $716K | 0.15% |
+12,679
| New | +$716K |
|
102
Honeywell
HON
$138B
| $709K | 0.15% |
3,307
+1,437
| +77% | +$308K |
|
103
Lockheed Martin
LMT
$106B
| $699K | 0.15% |
1,437
+213
| +17% | +$104K |
|
104
CVS Health
CVS
$94B
| $695K | 0.15% |
7,455
-1,040
| -12% | -$96.9K |
|
105
Marsh & McLennan
MMC
$101B
| $692K | 0.15% |
4,179
+1,941
| +87% | +$321K |
|
106
Thermo Fisher Scientific
TMO
$184B
| $677K | 0.14% |
1,230
+82
| +7% | +$45.2K |
|
107
Johnson Controls International
JCI
$69.3B
| $672K | 0.14% |
+10,504
| New | +$672K |
|
108
General Mills
GIS
$26.4B
| $666K | 0.14% |
7,947
+272
| +4% | +$22.8K |
|
109
Broadcom
AVGO
$1.4T
| $617K | 0.13% |
+1,104
| New | +$617K |
|
110
Bank of America
BAC
$373B
| $615K | 0.13% |
+18,584
| New | +$615K |
|
111
First Trust Dorsey Wright Focus 5 ETF
FV
$3.69B
| $614K | 0.13% |
+13,199
| New | +$614K |
|
112
Charles Schwab
SCHW
$174B
| $596K | 0.13% |
7,155
+3,055
| +75% | +$254K |
|
113
iShares Core US Aggregate Bond ETF
AGG
$130B
| $590K | 0.12% |
+6,080
| New | +$590K |
|
114
Oracle
ORCL
$633B
| $589K | 0.12% |
+7,209
| New | +$589K |
|
115
Wells Fargo
WFC
$262B
| $587K | 0.12% |
14,210
+4,583
| +48% | +$189K |
|
116
Expeditors International
EXPD
$16.4B
| $587K | 0.12% |
+5,646
| New | +$587K |
|
117
AT&T
T
$208B
| $575K | 0.12% |
31,253
+17,323
| +124% | +$319K |
|
118
Agilent Technologies
A
$35.6B
| $549K | 0.12% |
+3,668
| New | +$549K |
|
119
Equinix
EQIX
$75.5B
| $538K | 0.11% |
+822
| New | +$538K |
|
120
AstraZeneca
AZN
$249B
| $534K | 0.11% |
7,871
+2,881
| +58% | +$195K |
|
121
Mondelez International
MDLZ
$80B
| $532K | 0.11% |
7,978
+3,684
| +86% | +$246K |
|
122
Mettler-Toledo International
MTD
$26.3B
| $529K | 0.11% |
+366
| New | +$529K |
|
123
Goldman Sachs
GS
$221B
| $529K | 0.11% |
1,540
+726
| +89% | +$249K |
|
124
Novo Nordisk
NVO
$251B
| $526K | 0.11% |
3,885
+2,434
| +168% | +$329K |
|
125
Abbott
ABT
$229B
| $526K | 0.11% |
+4,787
| New | +$526K |
|